126 related articles for article (PubMed ID: 26745038)
1. Potential Benefit of Metformin as Treatment for Colon Cancer: the Evidence so Far.
Abdelsatir AA; Husain NE; Hassan AT; Elmadhoun WM; Almobarak AO; Ahmed MH
Asian Pac J Cancer Prev; 2015; 16(18):8053-8. PubMed ID: 26745038
[TBL] [Abstract][Full Text] [Related]
2. How far along are we in revealing the connection between metformin and colorectal cancer?
Berkovic MC; Mikulic D; Bilic-Curcic I; Mrzljak A
World J Gastroenterol; 2021 Apr; 27(14):1362-1368. PubMed ID: 33911461
[TBL] [Abstract][Full Text] [Related]
3. A new contribution for an old drug: Prospect of metformin in colorectal oncotherapy.
Jiang S; Lu Q
J Cancer Res Ther; 2021 Dec; 17(7):1608-1617. PubMed ID: 35381729
[TBL] [Abstract][Full Text] [Related]
4. Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase.
Algire C; Amrein L; Zakikhani M; Panasci L; Pollak M
Endocr Relat Cancer; 2010 Jun; 17(2):351-60. PubMed ID: 20228137
[TBL] [Abstract][Full Text] [Related]
5. Metformin for Prevention and Treatment of Colon Cancer: A Reappraisal of Experimental and Clinical Data.
Anisimov VN
Curr Drug Targets; 2016; 17(4):439-46. PubMed ID: 25738299
[TBL] [Abstract][Full Text] [Related]
6. Metformin and Colorectal Cancer - A Systematic Review.
Kobiela J; Dobrzycka M; Jędrusik P; Kobiela P; Spychalski P; Śledziński Z; Zdrojewski T
Exp Clin Endocrinol Diabetes; 2019 Jul; 127(7):445-454. PubMed ID: 29954001
[TBL] [Abstract][Full Text] [Related]
7. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.
Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714
[TBL] [Abstract][Full Text] [Related]
8. Metformin: a potential therapeutic agent for recurrent colon cancer.
Nangia-Makker P; Yu Y; Vasudevan A; Farhana L; Rajendra SG; Levi E; Majumdar AP
PLoS One; 2014; 9(1):e84369. PubMed ID: 24465408
[TBL] [Abstract][Full Text] [Related]
9. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
10. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
11. Metformin inhibited colitis and colitis-associated cancer (CAC) through protecting mitochondrial structures of colorectal epithelial cells in mice.
Wang SQ; Cui SX; Qu XJ
Cancer Biol Ther; 2019; 20(3):338-348. PubMed ID: 30359174
[TBL] [Abstract][Full Text] [Related]
12. Metformin: new understandings, new uses.
Hundal RS; Inzucchi SE
Drugs; 2003; 63(18):1879-94. PubMed ID: 12930161
[TBL] [Abstract][Full Text] [Related]
13. [Metformin can reduce the risk of colorectal cancer].
Fransgård T; Gögenur I
Ugeskr Laeger; 2015 May; 177(21):V12140659. PubMed ID: 26027593
[TBL] [Abstract][Full Text] [Related]
14. The Emerging Role of Metformin in the Prevention and Treatment of Colorectal Cancer: A Game Changer for the Management of Colorectal Cancer.
Ala M
Curr Diabetes Rev; 2022; 18(8):e051121197762. PubMed ID: 34749618
[TBL] [Abstract][Full Text] [Related]
15. Metformin-related colonic glucose uptake; potential role for increasing glucose disposal?--A retrospective analysis of (18)F-FDG uptake in the colon on PET-CT.
Bahler L; Stroek K; Hoekstra JB; Verberne HJ; Holleman F
Diabetes Res Clin Pract; 2016 Apr; 114():55-63. PubMed ID: 27103370
[TBL] [Abstract][Full Text] [Related]
16. Metformin, cancer and glucose metabolism.
Salani B; Del Rio A; Marini C; Sambuceti G; Cordera R; Maggi D
Endocr Relat Cancer; 2014; 21(6):R461-71. PubMed ID: 25273809
[TBL] [Abstract][Full Text] [Related]
17. The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus.
Lee JH; Kim TI; Jeon SM; Hong SP; Cheon JH; Kim WH
Int J Cancer; 2012 Aug; 131(3):752-9. PubMed ID: 21913184
[TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy.
Nobes JP; Langley SE; Klopper T; Russell-Jones D; Laing RW
BJU Int; 2012 May; 109(10):1495-502. PubMed ID: 21933330
[TBL] [Abstract][Full Text] [Related]
19. Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.
Sehdev A; Shih YC; Vekhter B; Bissonnette MB; Olopade OI; Polite BN
Cancer; 2015 Apr; 121(7):1071-8. PubMed ID: 25424411
[TBL] [Abstract][Full Text] [Related]
20. Metformin depresses overactivated Notch1/Hes1 signaling in colorectal cancer patients with type 2 diabetes mellitus.
Yang B; Huang CZ; Yu T; Zhou SN; Liu Q; Liu GJ; Chen S; Han FH
Anticancer Drugs; 2017 Jun; 28(5):531-539. PubMed ID: 28177944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]